CorVel Co. (NASDAQ:CRVL) Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp decreased its holdings in CorVel Co. (NASDAQ:CRVL - Free Report) by 4.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 232,515 shares of the business services provider's stock after selling 10,023 shares during the period. Boston Trust Walden Corp owned 1.35% of CorVel worth $76,007,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Janus Henderson Group PLC raised its position in CorVel by 997.8% in the 1st quarter. Janus Henderson Group PLC now owns 46,975 shares of the business services provider's stock worth $12,351,000 after purchasing an additional 42,696 shares during the period. Assenagon Asset Management S.A. raised its position in CorVel by 41.8% in the 2nd quarter. Assenagon Asset Management S.A. now owns 115,876 shares of the business services provider's stock worth $29,464,000 after purchasing an additional 34,155 shares during the period. Kayne Anderson Rudnick Investment Management LLC raised its position in CorVel by 1.1% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,925,635 shares of the business services provider's stock worth $489,631,000 after purchasing an additional 21,673 shares during the period. Sei Investments Co. raised its position in CorVel by 65.8% in the 1st quarter. Sei Investments Co. now owns 21,003 shares of the business services provider's stock worth $5,523,000 after purchasing an additional 8,338 shares during the period. Finally, State of New Jersey Common Pension Fund D purchased a new stake in CorVel in the 2nd quarter worth about $1,937,000. Institutional investors own 51.36% of the company's stock.

CorVel Stock Down 0.0 %

CorVel stock traded down $0.09 during midday trading on Friday, reaching $304.01. The stock had a trading volume of 14,344 shares, compared to its average volume of 35,264. The firm has a market cap of $5.21 billion, a price-to-earnings ratio of 67.41 and a beta of 1.08. The company has a fifty day moving average of $313.50 and a 200 day moving average of $280.26. CorVel Co. has a 52-week low of $187.92 and a 52-week high of $329.23.

CorVel (NASDAQ:CRVL - Get Free Report) last issued its earnings results on Tuesday, July 30th. The business services provider reported $1.25 EPS for the quarter. The business had revenue of $211.72 million for the quarter. CorVel had a net margin of 9.55% and a return on equity of 32.25%.

Insider Transactions at CorVel

In other news, Director R Judd Jessup sold 2,131 shares of the firm's stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $295.21, for a total transaction of $629,092.51. Following the transaction, the director now directly owns 43,277 shares of the company's stock, valued at approximately $12,775,803.17. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CFO Brandon O'brien sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $314.98, for a total transaction of $314,980.00. Following the transaction, the chief financial officer now directly owns 6,502 shares in the company, valued at approximately $2,047,999.96. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director R Judd Jessup sold 2,131 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $295.21, for a total transaction of $629,092.51. Following the transaction, the director now owns 43,277 shares in the company, valued at approximately $12,775,803.17. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 19,893 shares of company stock valued at $6,003,958. 47.57% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of CorVel from a "buy" rating to a "hold" rating in a research report on Saturday, August 31st.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.